Ovarian cancer has frequent loss of heterozygosity at chromosome 12pl2.3-13.1 (region of TEL and Kipi loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes
1997

Genetic Changes in Ovarian Cancer

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): Y Hatta, S Takeuchi, J Yokota, HP Koeffler

Primary Institution: Cedars-Sinai Research Institute, UCLA School of Medicine

Hypothesis

Are there new tumor-suppressor genes involved in ovarian cancer located on chromosome 12?

Conclusion

The study suggests that new tumor-suppressor genes on chromosomes 12p12.3-13.1 and 12q23-ter may play a role in the development of ovarian cancer.

Supporting Evidence

  • 26% of samples showed LOH at 12p12.3-13.1.
  • 30% of samples showed LOH at 12q23-ter.
  • LOH on chromosome 12 was more common in late-stage ovarian carcinomas.

Takeaway

Scientists looked at DNA from 23 ovarian cancer patients and found important changes in certain genes that might help explain how ovarian cancer develops.

Methodology

The study used polymerase chain reaction (PCR) to analyze loss of heterozygosity (LOH) in ovarian cancer samples.

Limitations

The sample size is small, and the study may not capture all genetic alterations in ovarian cancer.

Participant Demographics

All participants were Japanese women with ovarian cancer.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication